Clinical Trial Update: Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating carboplatin, bevacizumab, and pemetrexed in advanced non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Christiana Care Health Services | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-20